Pharmacokinetics and ascitic fluid penetration of piperacillin in cirrhosis
- PMID: 1794834
- DOI: 10.1111/j.1472-8206.1991.tb00768.x
Pharmacokinetics and ascitic fluid penetration of piperacillin in cirrhosis
Abstract
The pharmacokinetics of piperacillin were evaluated in seven healthy volunteers, eight cirrhotic patients without ascites and 11 cirrhotic patients with sterile ascites after a single 15-min intravenous infusion of 4 g of the drug. In ascitic patients, piperacillin rapidly entered the peritoneal fluid. Peritoneal concentrations were higher than 10 mg/l from 0.5 to 8 h after the infusion. Disappearance rate of piperacillin was slower in the ascitic fluid than in plasma. The plasma half life of piperacillin was more prolonged in cirrhotic patients that in control subjects. This difference was more marked in ascitic patients for whom half life was twice as high as in volunteers (1.95 versus 0.91 h; P less than 0.01).
Similar articles
-
Oral pharmacokinetics and ascitic fluid penetration of pefloxacin in cirrhosis.Eur J Clin Pharmacol. 1987;33(5):469-72. doi: 10.1007/BF00544237. Eur J Clin Pharmacol. 1987. PMID: 3480805
-
Oral pharmacokinetics and ascitic fluid penetration of ofloxacin in cirrhosis.Eur J Clin Pharmacol. 1989;37(3):261-5. doi: 10.1007/BF00679781. Eur J Clin Pharmacol. 1989. PMID: 2612541
-
The pharmacokinetics of ceftriaxone and cefotaxime in cirrhotic patients with ascites.Eur J Clin Pharmacol. 1989;36(6):613-6. doi: 10.1007/BF00637745. Eur J Clin Pharmacol. 1989. PMID: 2776819
-
[Dynamics of ascitic fluid in decompensated cirrhosis].Recenti Prog Med. 1999 Feb;90(2):94-9. Recenti Prog Med. 1999. PMID: 10208100 Review. Italian.
-
Pharmacokinetics of fluoroquinolones in hepatic failure.J Antimicrob Chemother. 1990 Oct;26 Suppl B:61-7. doi: 10.1093/jac/26.suppl_b.61. J Antimicrob Chemother. 1990. PMID: 2258353 Review.
Cited by
-
Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.Intensive Care Med. 2004 Dec;30(12):2145-56. doi: 10.1007/s00134-004-2428-9. Epub 2004 Nov 5. Intensive Care Med. 2004. PMID: 15536528 Review.
-
Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.Clin Pharmacokinet. 2005;44(10):1009-34. doi: 10.2165/00003088-200544100-00002. Clin Pharmacokinet. 2005. PMID: 16176116 Review.
-
Management of antimicrobial use in the intensive care unit.Drugs. 2012 Mar 5;72(4):447-70. doi: 10.2165/11599520-000000000-00000. Drugs. 2012. PMID: 22303918 Review.
-
Interprofessional Therapeutic Drug Monitoring of Piperacillin/Tazobactam Enhances Care for Patients with Acute-on-Chronic Liver Failure in the ICU: A Retrospective Observational Pilot Study.Antibiotics (Basel). 2025 Feb 14;14(2):202. doi: 10.3390/antibiotics14020202. Antibiotics (Basel). 2025. PMID: 40001445 Free PMC article.
-
Drug administration in chronic liver disease.Drug Saf. 1997 Jul;17(1):47-73. doi: 10.2165/00002018-199717010-00004. Drug Saf. 1997. PMID: 9258630 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical